United States Calcitonin Gene Related Peptide Type 1 Receptor Industry 2018 Market Research Report

Published: Dec, 2017 | Pages: 99 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States Calcitonin Gene Related Peptide Type 1 Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Calcitonin Gene Related Peptide Type 1 Receptor in these regions, from 2012 to 2022 (forecast).

United States Calcitonin Gene Related Peptide Type 1 Receptor market competition by top manufacturers/players, with Calcitonin Gene Related Peptide Type 1 Receptor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Allergan Plc
    Amgen Inc
    Biohaven Pharmaceutical Holding Company Ltd
    Eli Lilly and Company
    Fortress Biotech Inc
    Merck & Co Inc
    Teva Pharmaceutical Industries Ltd
    Vertex Pharmaceuticals Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    AFAP-3
    AGN-241689
    CGRP
    Erenumab
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cardiovascular
    Metabolic Disorders
    Dental Pain
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

United States Calcitonin Gene Related Peptide Type 1 Receptor Market Report 2017
1 Calcitonin Gene Related Peptide Type 1 Receptor Overview
    1.1 Product Overview and Scope of Calcitonin Gene Related Peptide Type 1 Receptor
    1.2 Classification of Calcitonin Gene Related Peptide Type 1 Receptor by Product Category
        1.2.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 AFAP-3
        1.2.4 AGN-241689
        1.2.5 CGRP
        1.2.6 Erenumab
        1.2.7 Others
    1.3 United States Calcitonin Gene Related Peptide Type 1 Receptor Market by Application/End Users
        1.3.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Cardiovascular
        1.3.3 Metabolic Disorders
        1.3.4 Dental Pain
        1.3.5 Others
    1.4 United States Calcitonin Gene Related Peptide Type 1 Receptor Market by Region
        1.4.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2012-2022)
        1.4.3 Southwest Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2012-2022)
        1.4.5 New England Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2012-2022)
        1.4.6 The South Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2012-2022)
        1.4.7 The Midwest Calcitonin Gene Related Peptide Type 1 Receptor Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Calcitonin Gene Related Peptide Type 1 Receptor (2012-2022)
        1.5.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2012-2022)
        1.5.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2012-2022)

2 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Competition by Players/Suppliers
    2.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Calcitonin Gene Related Peptide Type 1 Receptor Average Price by Players/Suppliers (2012-2017)
    2.4 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Competitive Situation and Trends
        2.4.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Concentration Rate
        2.4.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Base Distribution, Sales Area, Product Type

3 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Region (2012-2017)
    3.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Region (2012-2017)
    3.3 United States Calcitonin Gene Related Peptide Type 1 Receptor Price by Region (2012-2017)

4 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Type (2012-2017)
    4.3 United States Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2012-2017)
    4.4 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate by Type (2012-2017)

5 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (Volume) by Application (2012-2017)
    5.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Application (2012-2017)
    5.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Calcitonin Gene Related Peptide Type 1 Receptor Players/Suppliers Profiles and Sales Data
    6.1 Allergan Plc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Amgen Inc
        6.2.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Biohaven Pharmaceutical Holding Company Ltd
        6.3.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Eli Lilly and Company
        6.4.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Fortress Biotech Inc
        6.5.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Merck & Co Inc
        6.6.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Teva Pharmaceutical Industries Ltd
        6.7.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Vertex Pharmaceuticals Inc
        6.8.2 Calcitonin Gene Related Peptide Type 1 Receptor Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Cost Analysis
    7.1 Calcitonin Gene Related Peptide Type 1 Receptor Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Calcitonin Gene Related Peptide Type 1 Receptor

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Calcitonin Gene Related Peptide Type 1 Receptor Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Calcitonin Gene Related Peptide Type 1 Receptor Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume Forecast by Type (2017-2022)
    11.3 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume Forecast by Application (2017-2022)
    11.4 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Calcitonin Gene Related Peptide Type 1 Receptor
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (K Pcs) by Type (2012-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume Market Share by Type (Product Category) in 2016
    Figure AFAP-3 Product Picture
    Figure AGN-241689 Product Picture
    Figure CGRP Product Picture
    Figure Erenumab Product Picture
    Figure Others Product Picture
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (K Pcs) by Application (2012-2022)
    Figure United States Sales Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Application in 2016
    Figure Cardiovascular Examples
    Table Key Downstream Customer in Cardiovascular
    Figure Metabolic Disorders Examples
    Table Key Downstream Customer in Metabolic Disorders
    Figure Dental Pain Examples
    Table Key Downstream Customer in Dental Pain
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Market Size (Million USD) by Region (2012-2022)
    Figure The West Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Middle Atlantic Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
    Figure New England Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The South of US Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Midwest Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) and Growth Rate (2012-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Market Major Players Product Sales Volume (K Pcs) (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) of Key Players/Suppliers (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Players/Suppliers
    Figure 2017 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Players/Suppliers
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Market Major Players Product Revenue (Million USD) (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Players/Suppliers
    Figure 2017 United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Players/Suppliers
    Table United States Market Calcitonin Gene Related Peptide Type 1 Receptor Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
    Figure United States Market Calcitonin Gene Related Peptide Type 1 Receptor Average Price (USD/Pcs) of Key Players/Suppliers in 2016
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Market Share of Top 3 Players/Suppliers
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Calcitonin Gene Related Peptide Type 1 Receptor Product Category
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Region (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Region (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Region (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region in 2016
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Million USD) and Market Share by Region (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Region (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region in 2016
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Region (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Type (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Type (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Type (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type in 2016
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue  (Million USD) and Market Share by Type (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Type (2012-2017)
    Figure Revenue Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Type in 2016
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Types (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate by Type (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Application (2012-2017)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application in 2016
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate by Application (2012-2017)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate by Application (2012-2017)
    Table Allergan Plc Basic Information List
    Table Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Amgen Inc Basic Information List
    Table Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Biohaven Pharmaceutical Holding Company Ltd Basic Information List
    Table Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Eli Lilly and Company Basic Information List
    Table Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Fortress Biotech Inc Basic Information List
    Table Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Merck & Co Inc Basic Information List
    Table Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Teva Pharmaceutical Industries Ltd Basic Information List
    Table Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Vertex Pharmaceuticals Inc Basic Information List
    Table Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2012-2017)
    Figure Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share in United States (2012-2017)
    Figure Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share in United States (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Calcitonin Gene Related Peptide Type 1 Receptor
    Figure Manufacturing Process Analysis of Calcitonin Gene Related Peptide Type 1 Receptor
    Figure Calcitonin Gene Related Peptide Type 1 Receptor Industrial Chain Analysis
    Table Raw Materials Sources of Calcitonin Gene Related Peptide Type 1 Receptor Major Players/Suppliers in 2016
    Table Major Buyers of Calcitonin Gene Related Peptide Type 1 Receptor
    Table Distributors/Traders List
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue  (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) Forecast by Type (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) Forecast by Type (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) Forecast by Type in 2022
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) Forecast by Application (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) Forecast by Application (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) Forecast by Application in 2022
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume (K Pcs) Forecast by Region (2017-2022)
    Table United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Sales Volume Share Forecast by Region in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources